Quick Answer
Shuttle Pharmaceuticals Holdings, Inc. reported Net Income of -$11.72 million for fiscal year 2025.
Shuttle Pharmaceuticals Holdings, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$11.72M | -28.2% |
| 2024 | -$9.14M | -38.7% |
| 2023 | -$6.59M | -117.7% |
| 2022 | -$3.03M | -162.9% |
| 2021 | -$1.15M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.35M | +38.0% | +36.7% |
| June 30, 2025 | -$3.71M | -82.5% | -21.4% |
| March 31, 2025 | -$3.05M | -76.4% | +19.3% |
| September 30, 2024 | -$3.78M | -111.1% | -86.3% |
| June 30, 2024 | -$2.03M | +7.0% | -17.3% |
| March 31, 2024 | -$1.73M | -77.5% | +3.4% |
| September 30, 2023 | -$1.79M | -79.6% | +17.9% |
| June 30, 2023 | -$2.18M | -265.7% | -124.0% |
- Shuttle Pharmaceuticals Holdings, Inc. showed a decrease of -28.2% in Net Income compared to the prior fiscal year.
- Over the 2021–2025 period, Shuttle Pharmaceuticals Holdings, Inc.’s net income has declined by 917.4% (from -$1.15 million to -$11.72 million).
- The most recent figure is from Shuttle Pharmaceuticals Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: